{"id":"https://openalex.org/W3019905018","doi":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","title":"Economic challenges of oncological diseases\u2019 pharmacotherapy","display_name":"Economic challenges of oncological diseases\u2019 pharmacotherapy","alternate_titles":[],"publication_year":2020,"publication_date":"2020-04-24","ids":{"openalex":"https://openalex.org/W3019905018","doi":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","mag":"3019905018"},"language":"en","primary_location":{"id":"doi:10.17749/2070-4909.2020.13.1.64-70","doi":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","pdf_url":"https://www.pharmacoeconomics.ru/jour/article/download/343/314","source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3019905018"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.pharmacoeconomics.ru/jour/article/download/343/314","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066424632","display_name":"\u0415. \u0410. \u0423\u0448\u043a\u0430\u043b\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0003-4165-1726","observed_orcids":["https://orcid.org/0000-0003-4165-1726"]},"institutions":[{"id":"https://openalex.org/I126527374","display_name":"Peoples' Friendship University of Russia","ror":"https://ror.org/02dn9h927","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. A. Ushkalova","raw_affiliation_strings":["Peoples\u2019 Friendship University of Russia"],"raw_orcid":"https://orcid.org/0000-0003-4165-1726","affiliations":[{"raw_affiliation_string":"Peoples\u2019 Friendship University of Russia","institution_ids":["https://openalex.org/I126527374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001156655","display_name":"Sergey Kensarinovich Zyryanov","orcid":"https://orcid.org/0000-0002-6348-6867","observed_orcids":["https://orcid.org/0000-0002-6348-6867"]},"institutions":[{"id":"https://openalex.org/I126527374","display_name":"Peoples' Friendship University of Russia","ror":"https://ror.org/02dn9h927","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"S. K. Zyryanov","raw_affiliation_strings":["Peoples\u2019 Friendship University of Russia; City Clinical Hospital No. 24 of the Moscow Department of Health"],"raw_orcid":"https://orcid.org/0000-0002-6348-6867","affiliations":[{"raw_affiliation_string":"Peoples\u2019 Friendship University of Russia; City Clinical Hospital No. 24 of the Moscow Department of Health","institution_ids":["https://openalex.org/I126527374"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046386712","display_name":"\u0418. \u0410. \u0413\u043e\u043f\u0438\u0435\u043d\u043a\u043e","orcid":"https://orcid.org/0000-0003-3089-1804","observed_orcids":["https://orcid.org/0000-0003-3089-1804"]},"institutions":[{"id":"https://openalex.org/I126527374","display_name":"Peoples' Friendship University of Russia","ror":"https://ror.org/02dn9h927","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I. A. Gopienko","raw_affiliation_strings":["Peoples\u2019 Friendship University of Russia"],"raw_orcid":"https://orcid.org/0000-0003-3089-1804","affiliations":[{"raw_affiliation_string":"Peoples\u2019 Friendship University of Russia","institution_ids":["https://openalex.org/I126527374"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I126527374"],"apc_list":{"value":15000,"currency":"RUB","value_usd":142},"apc_paid":{"value":15000,"currency":"RUB","value_usd":142},"fwci":0.1715,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.56445245,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"13","issue":"1","first_page":"64","last_page":"70"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.7749999761581421},{"id":"https://openalex.org/keywords/financial-toxicity","display_name":"financial toxicity","score":0.7519999742507935},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6679999828338623},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.6190000176429749},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9100000262260437},{"id":"https://openalex.org/keywords/drug-price-negotiation","display_name":"drug price negotiation","score":0.6370000243186951},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.746999979019165},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9350000023841858},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.7603546380996704},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.7100235223770142},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6728246212005615},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5852601528167725},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4788053631782532},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4548223614692688},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.42254838347435},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4160487651824951},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3469243049621582},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3215176463127136},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17772695422172546},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.17269733548164368},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1459401249885559},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09238794445991516},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.17749/2070-4909.2020.13.1.64-70","doi":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","pdf_url":"https://www.pharmacoeconomics.ru/jour/article/download/343/314","source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","raw_type":"journal-article"},{"id":"pmh:oai:covid19.neicon.pro:dc/10135","doi":null,"is_oa":false,"landing_page_url":"https://covid19.neicon.ru/publication/10135","pdf_url":null,"source":{"id":"https://openalex.org/S7407055218","display_name":"COVID-19.\u0440\u0444: Information against the pandemic","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/journal-article"},{"id":"pmh:oai:doaj.org/article:a9c7cbe3d7214930af86e0436a5cf14f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a9c7cbe3d7214930af86e0436a5cf14f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u044d\u043a\u043e\u043d\u043e\u043c\u0438\u043a\u0430, Vol 13, Iss 1, Pp 64-70 (2020)","raw_type":"article"},{"id":"pmh:oai:oai.farmaec.elpub.ru:article/343","doi":null,"is_oa":true,"landing_page_url":"https://www.pharmacoeconomics.ru/jour/article/view/343","pdf_url":null,"source":{"id":"https://openalex.org/S4306401485","display_name":"PHARMACOECONOMICS (Eurasian Economic Community)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology; Vol 13, No 1 (2020); 64-70","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.17749/2070-4909.2020.13.1.64-70","doi":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","is_oa":true,"landing_page_url":"https://doi.org/10.17749/2070-4909.2020.13.1.64-70","pdf_url":"https://www.pharmacoeconomics.ru/jour/article/download/343/314","source":{"id":"https://openalex.org/S2764615430","display_name":"FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology","issn_l":"2070-4909","issn":["2070-4909","2070-4933"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/I4210126206","host_organization_name":"Irbis (Czechia)","host_organization_lineage":["https://openalex.org/I4210126206"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3019905018.pdf","grobid_xml":"https://content.openalex.org/works/W3019905018.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1532078022","https://openalex.org/W1939771758","https://openalex.org/W1968741068","https://openalex.org/W2021158896","https://openalex.org/W2046370192","https://openalex.org/W2050056063","https://openalex.org/W2069703793","https://openalex.org/W2099354636","https://openalex.org/W2115724268","https://openalex.org/W2117356576","https://openalex.org/W2121631836","https://openalex.org/W2132047269","https://openalex.org/W2134644638","https://openalex.org/W2135906122","https://openalex.org/W2147876556","https://openalex.org/W2149026758","https://openalex.org/W2150955627","https://openalex.org/W2153584585","https://openalex.org/W2154196284","https://openalex.org/W2168630917","https://openalex.org/W2246560172","https://openalex.org/W2266198524","https://openalex.org/W2292373964","https://openalex.org/W2301857081","https://openalex.org/W2368910722","https://openalex.org/W2395095892","https://openalex.org/W2415041554","https://openalex.org/W2473480037","https://openalex.org/W2514149552","https://openalex.org/W2529430742","https://openalex.org/W2541549125","https://openalex.org/W2552949065","https://openalex.org/W2590917827","https://openalex.org/W2600333833","https://openalex.org/W2609272592","https://openalex.org/W2619351549","https://openalex.org/W2767647212","https://openalex.org/W2783091042","https://openalex.org/W2785949980","https://openalex.org/W2889646458","https://openalex.org/W2889888469","https://openalex.org/W2904950382","https://openalex.org/W2914046442","https://openalex.org/W2917837889","https://openalex.org/W2921837178","https://openalex.org/W2943077196","https://openalex.org/W2943350255","https://openalex.org/W2945055514","https://openalex.org/W2948946518","https://openalex.org/W2958943734","https://openalex.org/W2969256165","https://openalex.org/W2994789075","https://openalex.org/W4247949143"],"related_works":["https://openalex.org/W3015209970","https://openalex.org/W4409812379","https://openalex.org/W2126346676","https://openalex.org/W4385589609","https://openalex.org/W3014054989","https://openalex.org/W2061661355","https://openalex.org/W2051159858","https://openalex.org/W2102120477","https://openalex.org/W2367080411"],"abstract_inverted_index":{"Oncological":[0],"diseases":[1],"rank":[2],"high":[3,36,89],"in":[4,48],"the":[5,21,24,49,54,74,77,80,101,115,126,133,139,168],"structure":[6],"of":[7,26,38,79,85,91,104,117,128,163],"population":[8],"morbidity":[9],"and":[10,16,110,148,152,157,161],"mortality.":[11],"They":[12],"entail":[13],"considerable":[14],"direct":[15],"indirect":[17],"economic":[18],"costs.":[19],"In":[20],"past":[22,50],"decades,":[23],"cost":[25,90,116],"oncotherapy":[27,92],"has":[28],"increased":[29,44],"significantly,":[30],"which":[31,41,129],"is":[32,93,120],"largely":[33],"conditioned":[34],"by":[35,45],"prices":[37],"antitumor":[39,165],"drugs,":[40],"on":[42,73,76],"average":[43],"ten":[46,51],"times":[47],"years.":[52],"At":[53],"same":[55],"time,":[56],"many":[57],"innovative":[58],"medications":[59,67],"have":[60],"only":[61],"minor":[62],"advantages":[63],"over":[64],"cheaper":[65],"old":[66],"because":[68],"they":[69],"are":[70],"registered":[71],"based":[72],"data":[75],"achievement":[78],"surrogate":[81],"endpoint":[82],"\u2013":[83],"extension":[84],"progression-free":[86],"survival.":[87,112],"The":[88],"associated":[94],"with":[95,138],"financial":[96],"toxicity":[97],"that":[98],"affects":[99],"negatively":[100],"patients\u2019":[102],"quality":[103],"life,":[105],"their":[106,155],"adherence":[107],"to":[108,122,135,144,158],"treatment":[109],"consequently":[111],"To":[113],"reduce":[114],"oncotherapy,":[118],"it":[119],"necessary":[121],"conduct":[123],"pharma-economic":[124],"analysis,":[125],"results":[127],"can":[130],"serve":[131],"as":[132,141,143,150,154],"basis":[134],"negotiate":[136],"price-cutting":[137],"manufacturers,":[140],"well":[142],"use":[145],"high-quality":[146],"generics":[147],"biosimilars":[149],"effective":[151],"safe":[153],"originals,":[156],"monitor":[159],"effectiveness":[160],"safety":[162],"all":[164],"drugs":[166],"within":[167],"pharmacovigilance":[169],"framework.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3019905018","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2020-05-01T00:00:00"}
